# US 2024/0252190 A1 · Acoustic shock wave or pressure pulse treatment for proptosis or exophthalmos

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0252190 A1
- Document ID: US20240252190A1
- Status: Published application
- Kind: A1
- Application number: 18/102,243
- Filed: 2023-01-27
- Published: 2024-08-01
- Earliest claimed: 2023-01-27
- Assignees: Softwave Tissue Regeneration Technologies, LLC
- Inventors: John F. Warlick
- Web page: https://patentgrep.com/patent/US20240252190A1

## CPC

- A61B 17/22004: {using mechanical vibrations, e.g. ultrasonic shock waves (A61B17/225 takes precedence)}
- A61C 19/06: Implements for therapeutic treatment (radiation therapy A61N5/00)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)

## Abstract

The device of the present invention allows for a method of treating a patient exhibiting proptosis of eye tissue by treating inflamed tissue behind the eye or treating the thyroid directly or treating a reflexology zone to reduce pressure and inflammation of the eye tissue using pressure pulses or shock waves. The treatment method for bulging eyes has the steps of placing an applicator head of an acoustic shock wave or pressure pulse generator or source on or near an eye or eyelid region, temple, thyroid or reflexology zone; coupling the applicator head directly or indirectly to an exposed surface of the region being treated; and activating the generator or source to emit pressure pulses or acoustic shock waves to the eye or eyelid region, temple, thyroid or reflexology zone to treat the eye tissue exhibiting high pressure and inflammation to reduce the pressure and inflammation.

## Claims

### Claim 1

A method of treating a patient exhibiting proptosis of eye tissue to reduce pressure and inflammation using pressure pulses or shock waves comprises the steps of:
placing an applicator head of an acoustic shock wave or pressure pulse generator or source near an eyelid or eye region of the patient;
coupling the applicator head directly or indirectly to an exposed surface of the skin near the eyelid or eye region; and
activating the generator or source to emit pressure pulses or acoustic shock waves to the eye tissue exhibiting high pressure and inflammation to reduce the high pressure and inflammation.

### Claim 2 (depends on 1)

The method of claim 1, wherein the emitted pressure pulses or acoustic shock waves are transmitted in a pattern passing through the eyelid skin to the eye tissue.

### Claim 3 (depends on 1)

The method of claim 1, wherein the emitted pressure pulses or acoustic shock waves pattern impinges the eye tissue.

### Claim 4 (depends on 1)

The method of claim 1, wherein the pressure pulse being an acoustic pulse which includes several cycles of positive and negative pressure.

### Claim 5 (depends on 4)

The method of claim 4, wherein the pressure pulse has an amplitude of the positive part of such a cycle should be above 0.1 MPa and the time duration of the pressure pulse is from below a microsecond to about a second.

### Claim 6 (depends on 5)

The method of claim 5, wherein the rise times of the positive part of the first pressure cycle in the range of nanoseconds (ns) up to some milliseconds (ms).

### Claim 7 (depends on 6)

The method of claim 6 wherein the acoustic shock waves being very fast pressure pulses having amplitudes above 0.1 MPa and rise times of the amplitude being below 1000 ns.

### Claim 8 (depends on 3)

The method of claim 3, wherein the duration of the shock wave is typically below 1-3 microseconds (μs) for the positive part of a cycle and typically above some microseconds for the negative part of a cycle.

### Claim 9 (depends on 3)

The method of claim 3, wherein subjecting the eye tissue to convergent, divergent, planar or near planar acoustic shock waves or pressure pulses in the absence of a focal point impinging the cells stimulating a cellular response in the absence of creating cavitation bubbles evidenced by not experiencing the sensation of hemorrhaging caused by the emitted waves or pulses in cells wherein the cells are positioned within a path of the emitted shock waves or pressure pulses; and away from any localized geometric focal volume or point of the emitted shock waves wherein the emitted shock waves or pressure pulses either have no geometric focal volume or point or have a focal volume or point ahead of the cells or beyond the cells thereby passing the emitted waves or pulses through the cells while avoiding having any localized focal point within the cells.

### Claim 10 (depends on 1)

The method of claim 1, wherein the emitted pressure pulses or shock waves are convergent, divergent, planar or near planar and the pressure pulse shock wave generator or source is based on electro-hydraulic, electromagnetic, piezoceramic or ballistic wave generation having an energy density value ranging as low as 0.00001 mJ/mm2 to a high end of below 1.0 mJ/mm2.

### Claim 11 (depends on 10)

The method of claim 10, wherein subjecting the eye tissue directly to the acoustic shock waves having a low energy density of less than 1.0 mJ/mm2 per shock wave stimulates said cells or eye tissue wherein the cells or eye tissue is positioned directly within a path of the emitted pressure pulses or acoustic shock waves in the absence of any focal point or if a focal point exists, the cells or eye tissue being treated is positioned away from any focal point.

### Claim 12 (depends on 11)

The method of claim 11, wherein the energy density is selected to avoid any cell damage to the cells or eye tissue.

### Claim 13 (depends on 1)

The method of claim 1, wherein treating the eye tissue to stimulate by accelerating or increasing cell growth or regeneration wherein the administering is applied to the patient who has a pathological condition of the eyes exhibiting damage caused by thyroid disease, injury or inflammation, any one of which has caused an increased pressure and inflammation which is reduced by the treatment.

### Claim 14 (depends on 1)

The method of treating the eye tissue of claim 1 stimulates by accelerating and increasing cell tissue growth or regeneration or repair in addition to reducing eye tissue swelling and pressure and inflammation and wherein the cell or eye tissue is from a mammal which is a human or an animal.

### Claim 15

A method of treating a patient exhibiting proptosis of eye tissue to reduce pressure and inflammation causing proptosis using pressure pulses or shock waves comprises the steps of:
placing an applicator head of an acoustic shock wave or pressure pulse generator or source near the temple of the patient;
coupling the applicator head directly or indirectly to an exposed surface of the skin near the temple; and
activating the generator or source to emit pressure pulses or acoustic shock waves to the eye tissue exhibiting high pressure and inflammation to reduce the high pressure and inflammation.

### Claim 16

A method of treating a patient exhibiting proptosis of eye tissue to reduce pressure and inflammation causing proptosis using pressure pulses or shock waves comprises the steps of:
placing an applicator head of an acoustic shock wave or pressure pulse generator or source near the thyroid of the patient;
coupling the applicator head directly or indirectly to an exposed surface of the skin near the eyelid or eye region; and
activating the generator or source to emit pressure pulses or acoustic shock waves to the eye tissue exhibiting high pressure and inflammation to reduce the high pressure and inflammation.

### Claim 17

A method of treating a patient exhibiting proptosis of eye tissue using a reflexology zone to reduce pressure and inflammation causing proptosis using pressure pulses or shock waves comprises the steps of:
placing an applicator head of an acoustic shock wave or pressure pulse generator or source near an eye or thyroid reflexology zone of the patient;
coupling the applicator head directly or indirectly to an exposed surface of the skin near the eye or thyroid reflexology zone; and
activating the generator or source to emit pressure pulses or acoustic shock waves to the eye or thyroid reflexology zone to treat the eye tissue exhibiting high pressure and inflammation to reduce the high pressure and inflammation.
